Department of Anesthesiology, Centre Claudius Regaud, IUCT-Oncopole, Toulouse.
Department of Anesthesiology and Critical Care, CH Hôtel-Dieu, Narbonne, France.
Clin J Pain. 2022 Jun 1;38(6):418-423. doi: 10.1097/AJP.0000000000001035.
In 2015, we evaluated our practices regarding pain after breast-conserving surgery. Thereafter, we have adapted our practices by performing a systematic deep serratus plane block before the surgical incision. In 2019, we assessed the impact of these changes in terms of chronic pain. The main objective of this study was to evaluate the prevalence of chronic pain 3 months after this type of surgery.
All patients treated with breast-conserving surgery as outpatients were included in this prospective study between April and July 2019. After inducing general anesthesia, 20 mL of ropivacaine 3.75 mg/mL were injected under the serratus muscle. Morphine titration was performed in the recovery room according to pain scores. A pain and quality of life questionnaire was sent 3 months after surgery. A backward logistic regression model was applied to calculate the adjusted odds ratios.
The final analysis involved 137 patients. Three months after surgery, 43 patients (31%) reported persistent pain related to the surgery. Maximum pain in the last 24 hours was moderate to severe in 60% of cases, 16 patients (35%) took painkillers. Morphine titration in the recovery room was required in 25 patients (18%). Younger age and the use of lidocaine to prevent after injection of propofol during general anesthesia induction appeared to be protective factors for the risk of pain at 3 months (secondary endpoints).
No persistent pain at 3 months was reported in 69% of cases. Furthermore, the use of a deep serratus anterior plane block before the surgical incision has limited the need for morphine titration in the recovery room to <1 patient in 5. These evaluations of professional practices should be encouraged.
2015 年,我们评估了保乳手术后疼痛管理的相关实践。此后,我们通过在手术切口前进行系统性的胸小肌平面阻滞来调整我们的实践。2019 年,我们评估了这些变化对慢性疼痛的影响。本研究的主要目的是评估这种手术类型 3 个月后慢性疼痛的发生率。
本前瞻性研究纳入了 2019 年 4 月至 7 月期间行保乳手术的所有门诊患者。全身麻醉诱导后,在胸小肌下注射 20ml 浓度为 3.75mg/ml 的罗哌卡因。根据疼痛评分在恢复室进行吗啡滴定。术后 3 个月时发送疼痛和生活质量问卷。应用向后逻辑回归模型计算调整后的优势比。
最终分析纳入了 137 例患者。术后 3 个月时,43 例(31%)患者报告与手术相关的持续性疼痛。60%的患者在过去 24 小时内的最大疼痛为中度至重度,16 例(35%)患者服用止痛药。25 例(18%)患者在恢复室需要吗啡滴定。年龄较小和在全身麻醉诱导期间使用利多卡因预防丙泊酚注射后疼痛似乎是 3 个月时疼痛风险的保护因素(次要终点)。
69%的患者报告术后 3 个月无持续性疼痛。此外,在手术切口前使用胸小肌前平面阻滞将恢复室中吗啡滴定的需求减少到每 5 例患者中不到 1 例。这些对专业实践的评估应得到鼓励。